Skip to main content
Heidi AI
EinloggenKostenfrei mit Heidi starten

Fragen Sie die KI zu Heidi:

Gastroenterologist Template

GI Follow up - IBD patient

A professional Gastroenterologist template for healthcare professionals.
Use this templateBrowse more templates
Browse more templates

About this template

Streamline your Inflammatory Bowel Disease (IBD) patient follow-up documentation with this dedicated GI Follow-up template. Designed for gastroenterologists, this template captures essential information including IBD diagnosis, detailed disease course, current treatments, preventative care, and comprehensive lab investigations. It facilitates a structured assessment of IBD status, outlines problem-specific plans for Ulcerative Colitis or Crohn's disease, colorectal cancer screening, and other gastrointestinal concerns. Perfect for ensuring thorough and consistent medical documentation, this template helps you maintain high standards of patient care. When used with Heidi, it efficiently extracts and organises critical clinical data from your consultations, making your note-taking process seamless and precise.

Preview template

The patient is a 34-year-old female, Ms. Sarah Jenkins, attending a follow-up consultation in the Gastroenterology clinic via video call. She was referred by her GP for ongoing management of her Inflammatory Bowel Disease. IBD PROFILE Diagnosis * Ulcerative Colitis, pancolitis, diagnosed in October 2018 by Dr. Eleanor Vance at St. Jude's Hospital. Summary of course * In October 2018, diagnosed with Ulcerative Colitis after presenting with bloody diarrhoea and abdominal pain. Initial treatment with oral Mesalazine 2.4g daily. FCP result was 1200 µg/g. * In April 2019, experienced a moderate flare, requiring a course of oral Prednisolone 40mg tapering over 8 weeks. Mesalazine dose increased to 4.8g daily. * In July 2020, developed steroid dependency. Commenced on Azathioprine 100mg daily. FCP result 450 µg/g. * In January 2021, Azathioprine discontinued due to persistent abnormal LFTs. Started on Vedolizumab 300mg IV at weeks 0, 2, 6, then every 8 weeks. Vedolizumab trough level 28 µg/mL. * In March 2022, remained in clinical remission. FCP result 75 µg/g. * In November 2023, reported mild increase in stool frequency, no blood. Vedolizumab trough level 25 µg/mL. FCP result 150 µg/g. Current Treatments: * Vedolizumab 300mg IV every 8 weeks (last dose 15 October 2024) * Mesalazine 4.8g daily (oral) Preventative * Vaccinations: * Influenza vaccine: October 2024 * Pneumococcal vaccine: September 2022 * Tetanus/Diphtheria/Pertussis: April 2021 * Infection screening: * HBV surface antigen: Negative (July 2020) * HCV antibody: Negative (July 2020) * TB Quantiferon Gold: Negative (July 2020) * CXR: Clear (July 2020) * Nutrition: * Follows a low FODMAP diet, avoiding lactose and gluten due to previous bloating. Reports good adherence and finds it helps with symptoms. Ms. Jenkins reports stable bowel movements, typically 1-2 soft stools per day, without blood or urgency. She denies any abdominal pain or tenesmus. Her weight has remained stable at 65 kg over the past six months. INVESTIGATIONS * HGB: 13.2 g/dL (28 October 2024) * WBC: 7.8 x10^9/L (28 October 2024) * Neutrophils: 4.5 x10^9/L (28 October 2024) * Lymphocytes: 2.5 x10^9/L (28 October 2024) * PLT: 280 x10^9/L (28 October 2024) * Ferritin: 85 ng/mL (28 October 2024) * CRP: 2 mg/L (28 October 2024) * Creatinine: 70 µmol/L (28 October 2024) * Vit. B12: 350 pg/mL (28 October 2024) * ALT: 25 U/L (28 October 2024) * AST: 20 U/L (28 October 2024) * ALP: 80 U/L (28 October 2024) * Albumin: 42 g/L (28 October 2024) * 6-TG: Not applicable (patient on Vedolizumab) * 6-MMP: Not applicable (patient on Vedolizumab) * FCP: 110 µg/g (28 October 2024) ASSESSMENT AND PLAN * The patient is a 34-year-old female with pancolitic Ulcerative Colitis, currently in clinical and biochemical remission on Vedolizumab and Mesalazine. Problem 1. Ulcerative Colitis, pancolitis. Ms. Jenkins remains in good clinical and biochemical remission on current therapy. Her FCP remains low and inflammatory markers are within normal limits. Vedolizumab treatment to continue as per current regimen. * Faecal Calprotectin: Annually (next due October 2025) Problem 2. CRC screening. Given her diagnosis of pancolitic Ulcerative Colitis for 6 years, regular colorectal cancer surveillance is recommended. Patient informed of recommendations. * Colonoscopy: Every 2 years (next due November 2025) Problem 3. Nutritional considerations. Ms. Jenkins is managing well on a low FODMAP diet. No signs of nutritional deficiencies currently. She will continue with her current dietary approach. Problem 4. Psychological well-being. Patient reports good mental health, no anxiety or depression related to her IBD. Continues to engage with a local support group. Next consultation scheduled in 6 months for routine follow-up, to be conducted via video call, approximately 1 May 2025.
[patient demographics, reason for consultation, and relevant background information including mode of consultation and clinic type] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely. Write in paragraphs of full sentences.) IBD PROFILE Diagnosis • [IBD diagnosis, classification, and onset details, including diagnosing physician] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely. Write as a list.) Summary of course • [chronological summary of the patient's IBD history, including initial diagnosis, treatment course, flares, complications, and significant events, including all relevant dates, medications, and physician names mentioned. Include all biological drug levels and all fecal calprotectin (FCP) results.] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely. Write as a list using full sentences, starting each item with the date using the format "In [month] [year]".) Current Treatments: • [current IBD medications and their dosages/frequencies] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely. Write as a list.) Preventative • Vaccinations: [list of vaccinations with dates] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely. Write as a list.) • Infection screening: [results of infection screenings for HBV, HCV, TB, and CXR status] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely. Write as a list.) • Nutrition: [details on patient's diet and any restrictions] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely. Write as a list.) [current symptoms, bowel movements, presence of pain, and weight stability] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely. Write in paragraphs of full sentences.) INVESTIGATIONS • [laboratory investigation results including HGB, WBC, Neutrophils, Lymphocytes, PLT, Ferritin, CRP, Creatinine, Vit. B12, ALT, AST, ALP, Albumin, 6-TG, 6-MMP, and FCP, with dates for each entry] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely. Write as a list.) ASSESSMENT AND PLAN • [patient's current IBD status, including age, gender, diagnosis, classification, and symptomatic state] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely. Write as a list.) Problem 1. [details regarding Ulcerative colitis or Crohn's disease as a problem, including investigations arranged and any IBD medical changes] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely. Write in paragraphs of full sentences.) • [specific investigations scheduled for Ulcerative colitis or Crohn's disease, with frequencies or dates] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely. Write as a list.) Problem 2. [details regarding CRC screening as a problem, including screening recommendations and next screening date] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely. Write in paragraphs of full sentences.) Problem 3. [details regarding other relevant gastrointestinal problems including possible causes and current management] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely. Write in paragraphs of full sentences.) Problem 4. [details regarding relevant gastrointestinal problems as a problem, including current status] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely. Write in paragraphs of full sentences.) [details regarding scheduling of next consultation, including time frame and mode of consultation] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely. Write in paragraphs of full sentences.) (Never come up with your own patient details, assessment, plan, interventions, evaluation, and plan for continuing care - use only the transcript, contextual notes or clinical note as a reference for the information include in your note. If any information related to a placeholder has not been explicitly mentioned in the transcript, contextual notes or clinical note, you must not state the information has not been explicitly mentioned in your output, just leave the relevant placeholder or omit the placeholder completely.) (Use as many lines, paragraphs or bullet points, depending on the format, as needed to capture all the relevant information from the transcript.)
Browse more templatesUse this template

How to use this template

Step 1: Download the template
1Step 1

Download the template

Get started by downloading the template to your device

Step 2: Customize to your needs
2Step 2

Customize to your needs

Tailor the template to match your specific requirements

Step 3: Deploy and share
3Step 3

Deploy and share

Implement your customized template and share with your team

Browse more templatesUse this template

Start practicing with a partner

Care is better with Heidi
Use this template

Specialty

Gastroenterologist

Used

9 times

Type

Note

Last edited

11.12.2025

Created by

Dustin Loomes

Related Templates

Note

Issues List (custom)

Anonymous

Gastroenterologist, Australia

Document

Formal clinic letter

Gastroenterologist, United Kingdom

Document

TG new letter template

Tom Goodsall

Gastroenterologist, Australia

Heidi AI

Heidi. Hält Ihnen den Rücken frei.

© 2026 Heidi. Alle Rechte vorbehalten.

Fachbereiche

  • Allgemeinmedizin

  • Fachärzt:innen

  • Psychologie

  • Therapeutische Gesundheitsberufe

  • Zahnmedizin

  • Tiermedizin

  • Studium & PJ

Compliance

  • Datenschutz

  • Trust Center

  • Compliance

Produkt

  • Preise

  • Downloads

  • Hilfe-Center

  • Systemstatus

  • Systemanforderungen

Über uns

  • Kontakt

  • Unternehmen

  • Kundengeschichten

  • Medien

  • Stellenangebote

    10+
  • Team

Ressourcen

  • Informationszentrum

  • Vorlagen-Community

  • Häufige Fragen

Rechtliches

  • Datenschutzrichtlinie

  • Servicebedingungen

  • Nutzungsrichtlinie

  • Barrierefreiheit

  • Impressum